Browse our anti-Solute Carrier Family 1 (Glutamate/Neutral Amino Acid Transporter), Member 4 (SLC1A4) Antibodies

Human Solute Carrier Family 1 (Glutamate/Neutral Amino Acid Transporter), Member 4 (SLC1A4) interaction partners

1. Results suggest that ASCT1/2 may play an important role in regulating extracellular d-serine and NMDA receptor-mediated physiological effects and that ASCT1/2 inhibitors have the potential for therapeutic benefit.

2. ANKRD50 simultaneously engages multiple parts of the SNX27 (show SNX27 Antibodies)-retromer-WASH complex machinery in a direct and co-operative interaction network that is needed to efficiently recycle the nutrient transporters

3. SLC1A4 deficiency should not be considered a population-specific disorder, and all patients with unexplained severe neurodevelopmental delay and the features outlined should be investigated regardless of ethnicity, as there are no known metabolic markers of this potentially treatable condition.

4. SLC1A4 is the disease causing gene of a novel neurologic disorder manifesting with significant intellectual disability, severe postnatal microcephaly, spasticity and thin corpus callosum.

5. ASCT1 is essential in brain serine transport.

6. SLC1A4 disruption may impair brain development and function by decreasing the levels of L-serine in neurons. The identification of additional families with mutations in SLC1A4 would be necessary to confirm its involvement in intellectual disability.

7. Na+ interactions with the neutral amino acid transporter ASCT1.

8. ASCT1 is able to mediate a concentrative transport of alanine, which is Na+-dependent but not coupled to the Na+ gradient

9. used as receptor by HERV-W Env glycoprotein (show ERVW-1 Antibodies)

10. results strongly suggest that combinations of amino acid sequence changes and N-linked oligosaccharides in a critical carboxyl-terminal region of extracellular loop 2 (ECL2) control retroviral utilization of both the ASCT1 and ASCT2 (show SLC1A5 Antibodies) receptors

Mouse (Murine) Solute Carrier Family 1 (Glutamate/Neutral Amino Acid Transporter), Member 4 (SLC1A4) interaction partners

1. ASCT1, rather than ASCT2 (show SLC1A5 Antibodies), is a component of the brain serine shuttle. ASCT1-KO mice display motor and neurodevelopmental deficits reminiscent of ASCT1 missense mutations in humans.

2. used as receptor by HERV-W Env glycoprotein (show ERVW-1 Antibodies) when their sites for N-glycosylation are eliminated by mutagenesis

3. ASCT1 expression was gradually downregulated in neuronal populations during late embryonic and neonatal periods, whereas its high expression was transmitted to radial glial cells and then to astrocytes; ASCT1 appears regulated to meet metabolic demands

4. results strongly suggest that combinations of amino acid sequence changes and N-linked oligosaccharides in a critical carboxyl-terminal region of extracellular loop 2 (ECL2) control retroviral utilization of both the ASCT1 and ASCT2 (show SLC1A5 Antibodies) receptors

5. either Phgdh (show PHGDH Antibodies) or ASCT1 is provided to each segment of renal tubules, suggesting that metabolic interplay mediated by L-serine biosynthesis and supply may exist in the kidney

6. Results demonstrate injury-induced changes in Phgdh (show PHGDH Antibodies) and ASCT1 expression.